Adocia Launches First-In-Man Clinical Study Of BioChaperone® Glucagon

ADOCIA a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced today the initiation of a Phase 1 study of BioChaperone® Glucagon, its aqueous formulation of human glucagon. The BioChaperone proprietary technology enables the solubilization and stabilization of human glucagon at neutral pH.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: